Vutrisiran CAS 1867157-35-4
Identification
CAS Number
1867157-35-4
Name
Vutrisiran
Properties
Safety Data
Symbol
Signal Word
Warning
WGK Germany
3
MSDS Download
Specifications and Other Information of Our
Identification Methods
HNMR, HPLC
Purity
Known Application
Vutrisiran is an investigational subcutaneously administered RNAi therapeutic indicated for the treatment of transthyretin-mediated (ATTR) amyloidosis, including hATTR and wild-type ATTR (wtATTR) amyloidosis. It blocks the production of wild-type and variant transthyretin (TTR) by targeting and silencing specific mRNAs.
General View of Documents
Links
This product is sold exclusively through our sales company Watson International Limited, and please click the link below for details (https://www.watson-int.com/).
